Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biontech Se ADR (NQ: BNTX )

108.97 -2.51 (-2.25%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biontech Se ADR

< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
64 65 Next >
Lyft And Uber Battle Over Earnings Ahead Of The Fed Announcement
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
Bulls Try To Build On Yesterday's Gains But Looming Fed Decision Could Curb Trading
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
What's Happening With BioNTech SE Shares?
Shares of vaccine companies, including BioNTech SE - ADR (NASDAQ: BNTX), are trading higher amid COVID-19 concerns due to rising cases in China. 
Via Benzinga
Moderna Bullish On COVID-19 Vaccine For Younger Kids To Be Ready Next Month: Reuters
Via Benzinga
April's Sell-Off Continues Into May As Futures Point To A Lower Open
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
Disappointing Earnings And A Spike In Inflation Send Stocks Plunging
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
Morning Brief: Top Financial Stories Dominating on Monday, May 2
CNBC Fourth COVID-19 Shot? See Why Medical Professionals Are Skeptical Medical professionals are undecided on whether a fourth dose of the Covid-19 vaccine would benefit the... 
Via Benzinga
Fourth COVID-19 Shot? See Why Medical Professionals Are Skeptical
Medical professionals are undecided on whether a fourth dose of the Covid-19 vaccine would benefit the wider population, as countries are beginning to offer the fourth dose to vulnerable groups. 
Via Benzinga
FDA Sets Review Dates For Pfizer, Moderna COVID-19 Shot For Kids, Plus Novavax EUA
Via Benzinga
Novavax Surges As Its Covid Shot Approaches The FDA Finish Line
The FDA advisory committee will meet June 7 to discuss its Covid shot. 
Via Investor's Business Daily
Morning Brief: Top Financial Stories Dominating on Thursday, April 28
CNBC Ford Motor Slashes 580 Jobs, Mainly In Engineering Ford Motor Co (NYSE: F) is slashing 580 U.S. salaried employees and agency workers as part of its ongoing Ford+... 
Via Benzinga
Six US States Probing Mysterious Liver Inflammation In Kids: Bloomberg
At least six U.S. states are reporting confirmed or suspected cases of an unexplained, severe liver disorder in children. Health officials in New York state and Wisconsin said they’re investigating... 
Via Benzinga
Market Briefing For Thursday, April 28
Strategizing trading in this market is virtually a fool's errand; nevertheless a lot of folks continue debating the trading dynamics as if to catch anything of an important nature. 
Via Talk Markets
The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
Pfizer, BioNTech Seeks Emergency Use Nod For COVID-19 Vaccine For Kids 5-11 Years
Via Benzinga
Market Briefing For Tuesday, April 26
The current risk of 'revolution' in China or famine in many parts of the 3rd world due to COVID or war, does not appear to be adequately realized by markets or governments. 
Via Talk Markets
Poland, Moderna Working Towards Increased Flexibility Of COVID-19 Vaccine Contracts: Reuters
Via Benzinga
If You Invested $1,000 In BioNTech Stock At Its Pandemic Low, Here's How Much You'd Have Now
Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better than... 
Via Benzinga
Novavax Stock Could Give Back More of Its Pandemic-Era Gains
While trading at a very low multiple to the low end of earnings estimates, NVAX stock may still be trading at a premium. 
Via InvestorPlace
Public-health Authorities in US, UK, Probe Mysterious Cases Of Severe Hepatitis In Young Kids: WSJ
Via Benzinga
Pfizer: What Comes After the Covid-19 Fire?
Success with Pfizer's Covid-19 vaccine maintains the PFE stock status as a dividend aristocrat, but don't expect miracles. 
Via InvestorPlace
7 Top-Rated Biotech Stocks to Buy for Q2
In these tumultous economic times, look to sectors that are outside the turmoil. Each of these seven biotech stocks fit the bill. 
Via InvestorPlace
4 Undervalued Biotech Stocks to Add to Your Buy List
These biotech stocks have seen their valuations tumble in the year-to-date sell-off. But they have the wherewithal to bounce big and generate decent, market-beating returns. 
Via InvestorPlace
UK-Based Start-Up Working On Next COVID-19 Vaccine Using Animal Feces: FT
Via Benzinga
Pfizer/BioNTech Fourth COVID-19 Vaccine Dose Protects Against Omicron For At Least One Month
A fourth dose of the COVID-19 vaccine from Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) provided significant protection against severe disease, hospitalization, and death for at least a month... 
Via Benzinga
AIM Puts mRNA Covid Vaccine in Investor Crosshairs With New IPO Attempt
Key takeaways: Vaccine maker AIM has filed for an IPO in Hong Kong, following unsuccessful previous bids in Hong Kong and on Shenzhen’s ChiNext board The company has three Covid vaccines under... 
Via Benzinga
Japan's Health Ministry Panel OKs Approval Of Novavax's COVID-19 Vaccine: Report
Via Benzinga
As Evolving Pandemic Response, Officials Shift To Personal Choice On COVID-19 Boosters, Masks: WSJ
In the latest phase of the COVID-19 pandemic, federal and local officials are leaving it up to people to assess if they need booster shots, whether to wear a mask and how long to isolate after a... 
Via Benzinga
Novavax: The Party’s Over
Novavax was a great speculation on hopes for its Covid-19 vaccine, but now that the virus is becoming endemic, sentiment is waning. 
Via InvestorPlace
The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Booster Data In Kids, Regeneron's COVID-19 Therapy Decision Pushed, Protagonist's Rusfertide Breakthrough Tag Update And More
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
64 65 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.